Related Experiment Video
Updated: Jun 14, 2026

Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.
Published on: September 1, 2015
Human plasmacytoid dendritic cell accumulation amplifies their type 1 interferon production
Anne P Liao1, Mohammad Salajegheh, Chris Morehouse
1Department of Neurology, Division of Neuromuscular Disease, Brigham and Women's Hospital, Boston, MA, USA.
Plasmacytoid dendritic cells (pDCs) amplify type 1 interferon production in autoimmune diseases. This amplification is IFNAR-dependent and suggests therapeutic potential for IFNAR blockade in treating these conditions.
Area of Science:
- Immunology
- Autoimmune Diseases
- Cell Biology
Background:
- Plasmacytoid dendritic cells (pDCs) accumulate in tissues during autoimmune diseases.
- Type 1 interferons (IFNs) play a critical role in autoimmunity.
- The precise mechanisms of pDC-mediated IFN production in situ are not fully understood.
Purpose of the Study:
- To investigate the relationship between pDC concentration and type 1 IFN production.
- To elucidate the role of interferon-alpha (IFN-α) and the type 1 interferon receptor (IFNAR) in human pDC IFN production.
- To assess the potential for therapeutic intervention targeting IFNAR.
Main Methods:
- Measurement of type 1 IFN production from human pDCs at varying concentrations.
- Assessment of IFN-α and IFNAR blockade effects on pDC IFN and interferon-inducible gene expression.
- Analysis of transcriptional and protein production related to IFN signaling.
Main Results:
- Human pDCs exhibit significantly enhanced IFN-α production at concentrations exceeding normal blood levels.
- This enhanced production is mediated by an IFNAR-dependent mechanism.
- Extracellular IFN-α amplifies pDC type 1 IFN production, leading to non-linear amplification in diseased tissues.
- The identified IFNAR-dependent mechanism in pDCs is more significant than previously recognized.
Conclusions:
- pDC accumulation in diseased tissues drives substantial local amplification of type 1 IFN production.
- IFNAR blockade represents a potential therapeutic strategy to reduce type 1 IFN production across various human cells.
- Understanding pDC-IFN interactions is crucial for developing targeted autoimmune therapies.
More Related Videos
13:34Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
Published on: March 17, 2014
10:00High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cell-mediated Immune Responses
Inhibitors of Viral Protein Synthesis
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.